Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series.

Literature DB >> 32424188

Use of anti-thymocyte globulin (ATG) for the treatment of pure red cell aplasia and immune-mediated cytopenias after allogeneic hematopoietic cell transplantation: a case series.

Alexandra Gomez-Arteaga¹, Michael Scordo^1,2, Roni Tamari^1,2, Josel D Ruiz¹, Ann A Jakubowski^1,2, Esperanza B Papadopoulos^1,2, Sergio A Giralt^1,2, Miguel-Angel Perales^1,2, Hugo R Castro-Malaspina^1,2, Craig S Sauter^1,2, Parastoo B Dahi^3,4.

Abstract

Entities: Disease

Mesh：

Substances：
Antilymphocyte Serum

Year: 2020 PMID： 32424188 DOI： 10.1038/s41409-020-0939-9

Source DB: PubMed Journal: Bone Marrow Transplant ISSN： 0268-3369 Impact factor: 5.483

× No keyword cloud information.

11 in total

1. Immune Cytopenias after Ex Vivo CD34+-Selected Allogeneic Hematopoietic Cell Transplantation.

Authors: Michael Scordo; Meier Hsu; Ann A Jakubowski; Gunjan L Shah; Christina Cho; Molly A Maloy; Scott T Avecilla; Esperanza B Papadopoulos; Boglarka Gyurkocza; Hugo Castro-Malaspina; Roni Tamari; Richard J O'Reilly; Miguel-Angel Perales; Sergio A Giralt; Brian C Shaffer
Journal: Biol Blood Marrow Transplant Date: 2019-01-06 Impact factor: 5.742

2. Horse versus rabbit antithymocyte globulin in acquired aplastic anemia.

Authors: Phillip Scheinberg; Olga Nunez; Barbara Weinstein; Priscila Scheinberg; Angélique Biancotto; Colin O Wu; Neal S Young
Journal: N Engl J Med Date: 2011-08-04 Impact factor: 91.245

3. Daratumumab for Delayed Red-Cell Engraftment after Allogeneic Transplantation.

Authors: Claudia I Chapuy; Richard M Kaufman; Edwin P Alyea; Jean M Connors
Journal: N Engl J Med Date: 2018-11-08 Impact factor: 91.245

4. Pure Red Cell Aplasia in Major ABO-Mismatched Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Severe Pancytopenia.

Authors: Fleur M Aung; Benjamin Lichtiger; Gabriela Rondon; C Cameron Yin; Amin Alousi; Sairah Ahmed; Borje S Andersson; Qaiser Bashir; Stefan O Ciurea; Chitra Hosing; Roy Jones; Partow Kebriaei; Issa Khouri; Yago Nieto; Betul Oran; Simrit Parmar; Muzaffar Qazilbash; Nina Shah; Elizabeth J Shpall; Richard E Champlin; Uday Popat
Journal: Biol Blood Marrow Transplant Date: 2016-02-26 Impact factor: 5.742

Review 5. Current concepts in the pathophysiology and treatment of aplastic anemia.

Authors: Neal S Young; Rodrigo T Calado; Phillip Scheinberg
Journal: Blood Date: 2006-06-15 Impact factor: 22.113

Review 6. Pure red cell aplasia following ABO mismatched marrow transplantation for chronic lymphocytic leukemia: response to antithymocyte globulin.

Authors: P J Bierman; P Warkentin; M R Hutchins; L W Klassen
Journal: Leuk Lymphoma Date: 1993-01

7. Pure red cell aplasia complicating an ABO-compatible allogeneic bone marrow transplantation, treated successfully with antithymocyte globulin.

Authors: D F Roychowdhury; C A Linker
Journal: Bone Marrow Transplant Date: 1995-09 Impact factor: 5.483

8. Resistant pure red cell aplasia after allogeneic stem cell transplantation with major ABO mismatch treated by escalating dose donor leukocyte infusion.

Authors: F Verholen; M Stalder; C Helg; Y Chalandon
Journal: Eur J Haematol Date: 2004-12 Impact factor: 2.997